Vyome Holdings Stock (NASDAQ:HIND)

Revenue Financials Chart Transcripts

Previous Close

$5.50

52W Range

$5.01 - $720.00

50D Avg

$8.10

200D Avg

$97.29

Market Cap

$133.69M

Avg Vol (3M)

$566.73K

Beta

1.06

Div Yield

-

HIND Company Profile

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Oct 06, 2016

Website

HIND Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 18
Product	$606.71K

Fiscal year ends in Dec 24 | Currency in USD

HIND Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$8.01M	$8.68M	$11.24M
Operating Income	$-6.67M	$-14.64M	$-27.08M
Net Income	$-7.13M	$-11.39M	$-46.21M
EBITDA	$-6.67M	$-14.48M	$-24.93M
Basic EPS	$-345.74	$-2.77K	$-157.90K
Diluted EPS	$-345.74	$-2.77K	$-157.90K

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 14, 24 | 4:30 PM

Q2 24Aug 15, 24 | 4:30 PM

Q1 24May 15, 24 | 4:30 PM

Peer Comparison

Ticker	Company
SINT	Sintx Technologies, Inc.
MTVA	MetaVia Inc.
NAOV	NanoVibronix, Inc.
ENSC	Ensysce Biosciences, Inc.
NUWE	Nuwellis, Inc.
PALI	Palisade Bio, Inc.